logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Manidipine CAS 89226-50-6

Manidipine CAS 89226-50-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 89226-50-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,Western Union,T/T,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
Light Yellow Crystalline Solid
CAS NO::
89226-50-6
Molecular Formula::
C35H38N4O6
Molecular Weight::
610.69900
EINECS NO::
855-394-4
MDL NO::
MFCD00871291
Appearance::
Light Yellow Crystalline Solid
CAS NO::
89226-50-6
Molecular Formula::
C35H38N4O6
Molecular Weight::
610.69900
EINECS NO::
855-394-4
MDL NO::
MFCD00871291
Manidipine CAS 89226-50-6

Product Description:

Product Name: Manidipine CAS NO: 89226-50-6


Synonyms:

1-diphenylmethyl-4-(2-hydroxyethyl)piperazine;

3-{2-[4-(diphenylMethyl)piperazin-1-yl]ethyl}5-Methyl2,6-diMethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;

Manidipine 6300;


Chemical & Physical Properties:

Appearance: Light yellow crystalline solid

Assay :≥99.00%

Density: 1.232 g/cm3

Boiling Point: 722℃ at 760 mmHg

Melting Point: 125-128℃

Flash Point: 390.4℃

Storage Condition: -20℃ Freezer

Vapor Pressure: 0.0±2.3 mmHg at 25℃

Index of Refraction: 1.601


A dihydropyridine calcium channel blocker. Antihypertensive. Manidipine (Manyper) is a lipophilic, third-generation, highly vasoselective dihydropyridine calcium antagonist with an IC50 of 2.6 nM. It causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells.

Manidipine is a calcium channel blocker that is used clinically as an antihypertensive. Target: Calcium ChannelManidipine is a dihydropyridine calcium antagonist, which causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. Manidipine was well tolerated in clinical trials, with most adverse effects related to vasodilation [1]. Manidipine is a lipophilic, third-generation dihydropyridine calcium channel antagonist with a high degree of selectivity for the vasculature, thereby inducing marked peripheral vasodilation with negligible cardiodepression. manidipine represents a first-line treatment option for patients with essential mild-to-moderate hypertension [2]. Manidipine has neutral effects on glucose and lipid metabolism and is generally well tolerated. Manidipine thus represents a first-line option for lowering BP in patients with mild-to-moderate hypertension [3].


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.